조혈모세포이식 환자에서 흔히 보는 감염

키워드

참고문헌 (55)

1. Wingard JR, "Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology", Infect Dis Clin North Am, 24, pp.257~272 (2010)
2. Dropulic LK, "Overview of infections in the immunocompromised host, In Diagnostic Microbiology of the Immunocompromised Host. 1st ed", pp.3~43 (2009), ASM Press
3. Tomblyn M, "Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients : a global perspective", Biol Blood Marrow Transplant, 15, pp.1143~1238 (2009)
4. Safdar A, "Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects", Clin Infect Dis, 53, pp.798~806 (2011)
5. Lee JW, "The activity of hematopoietic stem cell transplantation in Korea", Bone Marrow Transplant, 42(1), pp.92~95 (2008)
6. 이동건, "Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea", The Korean Journal of Internal Medicine, 26(2), pp.220~252 (2011), 대한내과학회
7. Jun HX, "Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever", Int J Antimicrob Agents, 26(2), pp.128~132 (2005)
8. 최수미, "급성 백혈병 환자의 감염양상 : 관해 유도 및 재관해유도 화학요법 환자군의 비교", Infection and Chemotherapy, 35(2), pp.78~85 (2003), 대한감염학회
9. Kim HB, "Infections in Patients with Acute Leukemia(1993-1996)", Korean J Hematol, 34, pp.359~365 (1999)
10. Yoo JH, "Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea", Bone Marrow Transplant, 34, pp.497~504 (2004)
11. Sun Hee Park, "Current Trends of Infectious Complications following Hematopoietic Stem Cell Transplantation in a Single Center", Journal of Korean Medical Science, 21(2), pp.199~207 (2006), 대한의학회
12. Kim SH, "Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens", Transpl Infect Dis (2012)
13. 권재철, "Epidemiology and Clinical Features of Bloodstream Infections in Hematology Wards: One Year Experience at the Catholic Blood and Marrow Transplantation Center", Infection and Chemotherapy, 45(1), pp.51~61 (2013), 대한감염학회[DOI]
14. Freifeld AG, "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America", Clin Infect Dis, 52, pp.56~93 (2011)
15. Leventakos K, "Fungal infections in leukemia patients: how do we prevent and treat them?", Clin Infect Dis, 50, pp.405~415 (2010)
16. Pappas PG, "Clinical practice guidelines for the management of candidiasis : 2009 update by the Infectious Diseases Society of America", Clin Infect Dis, 48, pp.503~535 (2009)
17. De Pauw B, "Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer", Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC, Clin Infect Dis, pp.2008, 46[DOI]
18. Marchetti O, "ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients", Bone Marrow Transplant, 47, pp.846~854 (2012)
19. Walsh TJ, "Treatment of aspergillosis : clinical practice guidelines of the Infectious Diseases Society of America", Clin Infect Dis, 46, pp.327~360 (2008)
20. Michallet M, "Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation", J Clin Oncol, 27, pp.3398~3409 (2009)
21. Maschmeyer G, "Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients : guidelines of the infectious diseases working party of the German Society of Haematology and Oncology", Eur J Cancer, 45, pp.2462~2472 (2009)
22. Pagano L, "Current therapeutic approaches to fungal infections in immunocompromised hematological patients", Blood Rev, 24, pp.51~61 (2010)
23. Maertens J, "European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients : summary of the ECIL 3 : 2009 update", Bone Marrow Transplant, 46, pp.709~718 (2011)
24. 최수미, "Current Antimicrobial Usage for the Management of Neutropenic Fever in Korea: A Nationwide Survey", Journal of Korean Medical Science, 23(6), pp.941~947 (2008), 대한의학회
25. Herbrecht R, "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis", N Engl J Med, 347, pp.408~415 (2002)
26. Upton A, "Invasive aspergillosis following hematopoietic cell transplantation : outcomes and prognostic factors associated with mortality", Clin Infect Dis, 44, pp.531~540 (2007)
27. Schubert MM, "Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation : analysis of factors associated with infection", Oral Surg Oral Med Oral Pathol, 70, pp.286~293 (1990)
28. Lee JT, "Prevalence of antibody to herpes simplex virus", Korean J Dermatol, 31, pp.38~46 (1993)
29. Ljungman P, "Definitions of cytomegalovirus infection and disease in transplant recipients", Clin Infect Dis, 34, pp.1094~1097 (2002)
30. Ljungman P, "Management of CMV infections : recommendations from the infectious diseases working party of the EBMT", Bone Marrow Transplant, 33, pp.1075~1081 (2004)
31. 최수미, "Comparison of Quantitative Cytomegalovirus Real-time PCR in Whole Blood and pp65 Antigenemia Assay: Clinical Utility of CMV Real-time PCR in Hematopoietic Stem Cell Transplant Recipients", Journal of Korean Medical Science, 24(4), pp.571~578 (2009), 대한의학회
32. Choi SM, "Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation : a single-center experience in Korea", Int J Hematol, 81, pp.69~74 (2005)
33. 최수미, "조혈모세포이식 환자에서 발생한 Cytomegalovirus 질환의 특징 : 일개 대학병원에서 최근 10년간의 경험", Infection and Chemotherapy, 41(1), pp.9~19 (2009), 대한감염학회
34. Jeon S, "Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation", Ophthalmology, 119, pp.1892~1898 (2012)
35. Park SH, "Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation : comparison with anti-thymocyte globulin", Transpl Infect Dis, 11, pp.413~423 (2009)
36. Bergeron A, "The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies", Blood, 119, pp.1831~1837 (2012)
37. Ju JH, "Pneumocystis carinii pneumonia following stem cell transplantation", Korean J Infect Dis, 33, pp.273~279 (2001)
38. Sun Hee Park, "Clinical Characteristics and Outcomes of Posttransplant Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation in Korea", Journal of Korean Medical Science, 21(2), pp.259~264 (2006), 대한의학회
39. Kim YJ, "Human herpesvirus-6 as a possible cause of encephalitis and hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation", Leukemia, 16, pp.958~959 (2002)
40. Dropulic LK, "Polyomavirus BK infection in blood and marrow transplant recipients", Bone Marrow Transplant, 41, pp.11~18 (2008)
41. Ison MG, "Adenovirus infections in transplant recipients", Clin Infect Dis, 43, pp.331~339 (2006)
42. Leung AY, "Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation", Blood, 98, pp.1971~1978 (2001)
43. Erard V, "BK DNA viral load in plasma : evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients", Blood, 106, pp.1130~1132 (2005)
44. 김성용, "동종조혈모세포이식 후 발생한 성인 출혈성방광염 환자의 바이러스뇨증과 항바이러스 치료", Blood Research, 42(2), pp.5~5 (2007), 대한혈액학회
45. Hammarström V, "Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients", Transplantation, 69, pp.1582~1586 (2000)
46. Lee DG, "Hematopoietic stem cell transplantation. In: Cheong HJ, ed. Vaccination for adults. 2nd ed", pp.380~388 (2012), MIP Press
47. Weigt SS, "Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients", Semin Respir Crit Care Med, 32, pp.471~493 (2011)
48. Kumar D, "Respiratory viral infections in transplant and oncology patients", Infect Dis Clin North Am, 24, pp.395~412 (2010)
49. Campbell AP, "and clinical outcomes of HCT", J Infect Dis, 201, pp.1404~1413 (2010)
50. Lee DG, "Characteristics of respiratory tract infection in the hematopoietic stem cell transplantation population", Korean J Infect Dis, 33, pp.419~429 (2001)
51. Choi WS, "Seroprevalence of varicella-zoster virus in Korea", J Med Virol, 82, pp.2123~2126 (2010)
52. Kim DH, "Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation", Clin Transplant, 22, pp.770~779 (2008)
53. Russo RL, "Tuberculosis in hematopoietic stem cell transplant patients: case report and review of the literature", Int J Infect Dis, 14(3), pp.187~191 (2010)
54. Lee J, "Tuberculosis in hematopoietic stem cell transplant recipients in Korea", Int J Hematol, 79, pp.185~188 (2004)
55. ". Seoul: Joint Committee for the Development of Korean Guidelines for Tuberculosis"[URL]

관련 논문AI추천